|
Index | S&P 500 | P/E | 17.16 | EPS (ttm) | 4.17 | Insider Own | 0.14% | Shs Outstand | 453.93M | Perf Week | 3.04% |
Market Cap | 32.56B | Forward P/E | - | EPS next Y | - | Insider Trans | 0.00% | Shs Float | 453.28M | Perf Month | 21.51% |
Income | 1.90B | PEG | - | EPS next Q | - | Inst Own | 20.33% | Short Float / Ratio | 2.73% / 3.22 | Perf Quarter | - |
Sales | 18.34B | P/S | 1.78 | EPS this Y | 11.10% | Inst Trans | - | Short Interest | 12.36M | Perf Half Y | - |
Book/sh | - | P/B | - | EPS next Y | - | ROA | - | Target Price | - | Perf Year | - |
Cash/sh | 1.10 | P/C | 65.12 | EPS next 5Y | - | ROE | - | 52W Range | 53.00 - 73.95 | Perf YTD | 22.70% |
Dividend | - | P/FCF | 44.91 | EPS past 5Y | - | ROI | 13.20% | 52W High | -3.14% | Beta | - |
Dividend % | - | Quick Ratio | 0.80 | Sales past 5Y | - | Gross Margin | 39.10% | 52W Low | 35.15% | ATR | 2.96 |
Employees | 51000 | Current Ratio | 1.10 | Sales Q/Q | -47.40% | Oper. Margin | 13.70% | RSI (14) | 66.56 | Volatility | 3.35% 4.29% |
Optionable | Yes | Debt/Eq | 0.00 | EPS Q/Q | -58.00% | Profit Margin | 10.60% | Rel Volume | 0.50 | Prev Close | 71.86 |
Shortable | Yes | LT Debt/Eq | 0.00 | Earnings | Jan 30 BMO | Payout | 0.00% | Avg Volume | 3.84M | Price | 71.63 |
Recom | 2.00 | SMA20 | 6.79% | SMA50 | 13.45% | SMA200 | 13.45% | Volume | 1,930,345 | Change | -0.32% |
![]() | ||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is based in Chicago, Illinois. | ||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||
![]() |
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite